Getting a kidney transplant is one of the longest, most complex processes in modern medicine. From the initial evaluation to surgery day, most people spend years navigating medical tests, compatibility requirements, and a waiting list with far more candidates than available organs. As of December 2023, roughly 61,000 people were on the national kidney transplant waiting list, and each year only a fraction receive a transplant while thousands are removed because they died or became too sick for surgery.
The Evaluation Takes Months
Before you can even join the waiting list, you need to complete a full transplant workup at a certified transplant center. This involves blood work, heart and lung testing, cancer screenings, psychological evaluations, and meetings with social workers and financial counselors. The median time from starting this evaluation to being officially registered on the waiting list is about 8 to 9 months, though it can stretch to over a year if additional health issues need to be addressed first. Data from both U.S. and European centers consistently show this timeline.
Not everyone who starts the evaluation gets listed. Transplant centers assess whether the surgery and the lifelong immune-suppressing medications that follow would do more good than harm. Conditions that can disqualify you include cancer that’s likely to progress, severe heart or lung disease, extreme obesity (BMI over 45), active substance use disorders, a life expectancy under five years even with a successful transplant, or the inability to reliably follow a post-transplant medication regimen. A lack of social support, meaning someone to help you during recovery and keep up with appointments, can also prevent listing.
Age alone doesn’t disqualify you. The proportion of people aged 65 to 74 on the waiting list has grown from 2% in the 1990s to over 10% in recent years. Transplant guidelines in both the U.S. and Canada state that advanced age is not a contraindication as long as no other medical or surgical issues rule it out.
Biological Compatibility Narrows the Field
Even when a kidney becomes available, it has to be a biological match. Three factors determine compatibility: blood type, tissue typing, and a crossmatch test that checks for harmful antibodies.
Blood type rules work the same as blood transfusions. Type O donors can give to anyone, while type AB recipients can receive from anyone. If you have type O blood and need a kidney, you can only receive from another type O donor, which limits your pool. Tissue typing looks at six key protein markers on your cells. Except between identical twins or some siblings, a perfect six-marker match between two people is rare, especially if they’re unrelated. A closer match generally means a lower risk of rejection.
The crossmatch test is the final gate. If your blood contains antibodies that react against a specific donor’s tissue markers, that kidney would almost certainly be rejected. People develop these antibodies through previous blood transfusions, pregnancies, infections, or even common viral illnesses. The more antibodies you carry, the harder it is to find a compatible donor, and some highly sensitized patients wait significantly longer than average.
Wait Times Vary Dramatically by Location and Race
There is no single national wait time for a kidney. Where you live plays an enormous role. In regions like New England and the western U.S. (California, Arizona, Nevada, Utah), candidates reached the waiting list faster, with 25th-percentile times to listing around 810 to 860 days. In the Southeast (Alabama, Georgia, Florida, Louisiana, Mississippi), that figure climbed to over 1,300 days for white patients and nearly 1,800 days for Black patients.
Racial disparities persist across almost every region. Nationally, Black patients waited a median of 1,402 days to reach the transplant waiting list compared to 1,059 days for white patients, a gap of nearly a year. In some regions, particularly in the South, Midwest, and mid-Atlantic states, the gap exceeded 300 to 400 days. These differences reflect a combination of factors: unequal access to nephrology referrals, differences in insurance coverage, and systemic biases in the evaluation process.
What Happens on the Waiting List
Once listed, the wait for a deceased donor kidney is measured in years for most candidates. The median age on the list is 55, and more than 30,000 dialysis patients are added each year. In 2022, 4,454 candidates were removed from the list because they died, and another 4,504 were removed for becoming too sick to undergo surgery. That means roughly 9,000 people in a single year lost their chance at a transplant while waiting.
The allocation system prioritizes based on time spent waiting, medical urgency, compatibility, and geographic distance from the donor hospital. Being listed at multiple transplant centers (if you can manage the travel and repeated evaluations) is allowed and can improve your odds, though it adds cost and complexity.
Living Donors Change the Math
A living donor kidney is the single most effective way to shorten or bypass the wait. For adult recipients aged 18 to 34, five-year graft survival is about 89% with a living donor compared to 81% with a deceased donor. For recipients 65 and older, the gap widens: 82% versus 68%. Pediatric recipients see even stronger outcomes, with living donor kidneys functioning at five years in about 93% of cases versus 85% for deceased donor kidneys.
If you have a willing donor who isn’t a biological match, kidney paired exchange programs offer another route. These programs work like a swap: your incompatible donor gives a kidney to a stranger whose donor is incompatible with them but compatible with you, and vice versa. In large exchange programs, about 32% of enrolled candidates received a matched kidney within three months, and 46% within a year. The median wait for candidates with common blood types and low antibody levels was as short as two months, though people with type O blood or high antibody levels often waited over a year even within these programs.
The Financial Side
Kidney failure qualifies you for Medicare regardless of your age, which covers the transplant surgery, hospital stay, and related lab work. Under Medicare Part B, you pay 20% of approved charges for outpatient services after meeting your deductible, and there’s no cost for the donor’s surgical expenses. However, Medicare’s coverage of post-transplant immune-suppressing medications used to expire 36 months after the transplant, a gap that left some recipients unable to afford the drugs that keep their new kidney alive. Recent legislation has extended that coverage, but the specifics depend on your other insurance.
Private insurance and Medicaid cover transplants as well, but out-of-pocket costs for deductibles, copays, travel to the transplant center, and time off work add up. Many transplant centers require proof that you can afford or access post-transplant medications before they’ll list you, because stopping those drugs means losing the kidney. Nonprofit organizations and hospital financial assistance programs exist to help fill gaps, but navigating them takes time and persistence.
Why Some People Never Get Listed
The hardest part of getting a kidney transplant, for many people, isn’t the surgery or the wait. It’s getting through the door. Studies consistently show that a large share of patients with kidney failure are never referred to a transplant center, never complete the evaluation, or are turned away for reasons that don’t always reflect strict medical criteria. Patients without strong insurance, without transportation to a transplant center, or without a support network face structural barriers that compound the biological and logistical ones. The process rewards people who can advocate for themselves, follow up relentlessly, and absorb the financial and emotional costs of a years-long journey.